Avalo Therapeutics
AVTX
AVTX
26 hedge funds and large institutions have $16M invested in Avalo Therapeutics in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
43% less capital invested
Capital invested by funds: $28M → $16M (-$12M)
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.28M | |
| 2 | +$1.97M | |
| 3 | +$1.56M | |
| 4 |
AC
Armistice Capital
New York
|
+$1.48M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.31M |
Top Sellers
| 1 | -$95K | |
| 2 | -$79K | |
| 3 | -$12.6K | |
| 4 |
MAM
Meeder Asset Management
Dublin,
Ohio
|
-$4.73K |
| 5 |
Goldman Sachs
New York
|
-$3.15K |